Dual HER2 blockade: preclinical and clinical data

Chang, Perez, and colleagues, review recent data on different combinations of anti-human epidermal growth factor receptor (HER2) treatments, as part of the ‘recent advances in breast cancer treatment’ special series.

Source: Breast Cancer Research - July 31, 2014 Category: Cancer & Oncology Authors: Tejal PatelBhuvanesh DaveAngel RodriguezJenny ChangEdith PerezGerardo Colon-Otero Source Type: research